Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11177 - 11184 of 11616 results
Massachusetts Supreme Judicial Court Affirms Lower Court Ruling in Favor of Employees Misclassified as Franchisees/Independent Contractors
September 13, 2011| Blog| Viewpoint
OIG Advisory Opinion Permits Donation of Telemedicine Items and Services
September 12, 2011| Blog| Viewpoint
State of New York Forms Task Force Targeting Excessive Compensation at Nonprofits
September 9, 2011| Blog| Viewpoint
Creative Trademark Licensing Presents Business Opportunities
September 8, 2011| Blog| Viewpoint
NLRB Requires Non-Union Employers to Post Unionization Rights Notices
September 7, 2011| Blog| Viewpoint
Federal Appeals Court Rules Tribal Issuer's Trust Indenture is a Void "Management Contract"
September 7, 2011| Blog| Viewpoint
H.R. 2511 Offers Legal Protections For Fashion Design
September 2, 2011| Blog| Viewpoint
Employers May Need to Provide Employees with Leave For Involvement With School-Related Activities
September 1, 2011| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.